Patient Lifestyle

What will the future of senior care look like in Alberta as the province kicks off major change? New legislation could lead to fewer controls, some healthcare professionals worry.

Guidelines feature evidence behind current treatments and therapies still in trials.

Diffuse pain, severe fatigue, sleep problems, difficulty concentrating, gastrointestinal disorders, depression, anxiety—these symptoms and more make diagnosis complex.

New recommendations from Collège des médecins du Québec and Ordre des pharmaciens du Québec.

An allegory about a man and his sword from Dr. Jabir Jassam.

Expert in the rare but commonly overlooked disease encourages practitioners to initiate therapy sooner rather than later.

Keytruda and chemotherapy were found to increase median overall survival to 12.9 months, compared with 11.5 months on just chemotherapy.

As of December, the firm has paid $11.2 million in compensation.